Back to article: Red blood cell extracellular vesicles as robust carriers of RNA-based therapeutics

FIGURE 1: Schematic overview of the advantages and potential applications of the red blood cell extracellular vesicles (RBCEVs) delivery system of RNA-based therapeutics.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.